United States Peptide Vaccine Market Report 2017

December 2017 | 99 pages | ID: U7256C46404EN
QYResearch

Abstracts

In this report, the United States Peptide Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Peptide Vaccine in these regions, from 2012 to 2022 (forecast).

United States Peptide Vaccine market competition by top manufacturers/players, with Peptide Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Inovio Pharmaceuticals
• Synthetic Genomics
• GreenPeptide
• AmbioPharm
• Rhapsody Biologics

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Synthetic Peptide Vaccine
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Medical Center
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Peptide Vaccine Market Report 2017

1 PEPTIDE VACCINE OVERVIEW

1.1 Product Overview and Scope of Peptide Vaccine
1.2 Classification of Peptide Vaccine by Product Category
  1.2.1 United States Peptide Vaccine Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Peptide Vaccine Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Synthetic Peptide Vaccine
  1.2.4 Others
1.3 United States Peptide Vaccine Market by Application/End Users
  1.3.1 United States Peptide Vaccine Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Medical Center
  1.3.4 Others
1.4 United States Peptide Vaccine Market by Region
  1.4.1 United States Peptide Vaccine Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Peptide Vaccine Status and Prospect (2012-2022)
  1.4.3 Southwest Peptide Vaccine Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Peptide Vaccine Status and Prospect (2012-2022)
  1.4.5 New England Peptide Vaccine Status and Prospect (2012-2022)
  1.4.6 The South Peptide Vaccine Status and Prospect (2012-2022)
  1.4.7 The Midwest Peptide Vaccine Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Peptide Vaccine (2012-2022)
  1.5.1 United States Peptide Vaccine Sales and Growth Rate (2012-2022)
  1.5.2 United States Peptide Vaccine Revenue and Growth Rate (2012-2022)

2 UNITED STATES PEPTIDE VACCINE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Peptide Vaccine Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Peptide Vaccine Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Peptide Vaccine Average Price by Players/Suppliers (2012-2017)
2.4 United States Peptide Vaccine Market Competitive Situation and Trends
  2.4.1 United States Peptide Vaccine Market Concentration Rate
  2.4.2 United States Peptide Vaccine Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Peptide Vaccine Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES PEPTIDE VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Peptide Vaccine Sales and Market Share by Region (2012-2017)
3.2 United States Peptide Vaccine Revenue and Market Share by Region (2012-2017)
3.3 United States Peptide Vaccine Price by Region (2012-2017)

4 UNITED STATES PEPTIDE VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Peptide Vaccine Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Peptide Vaccine Revenue and Market Share by Type (2012-2017)
4.3 United States Peptide Vaccine Price by Type (2012-2017)
4.4 United States Peptide Vaccine Sales Growth Rate by Type (2012-2017)

5 UNITED STATES PEPTIDE VACCINE SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Peptide Vaccine Sales and Market Share by Application (2012-2017)
5.2 United States Peptide Vaccine Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES PEPTIDE VACCINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Inovio Pharmaceuticals
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Peptide Vaccine Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Inovio Pharmaceuticals Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Synthetic Genomics
  6.2.2 Peptide Vaccine Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Synthetic Genomics Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 GreenPeptide
  6.3.2 Peptide Vaccine Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 GreenPeptide Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 AmbioPharm
  6.4.2 Peptide Vaccine Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 AmbioPharm Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Rhapsody Biologics
  6.5.2 Peptide Vaccine Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Rhapsody Biologics Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview

7 PEPTIDE VACCINE MANUFACTURING COST ANALYSIS

7.1 Peptide Vaccine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Peptide Vaccine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Peptide Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Peptide Vaccine Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES PEPTIDE VACCINE MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Peptide Vaccine Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Peptide Vaccine Sales Volume Forecast by Type (2017-2022)
11.3 United States Peptide Vaccine Sales Volume Forecast by Application (2017-2022)
11.4 United States Peptide Vaccine Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Peptide Vaccine
Figure United States Peptide Vaccine Market Size (K Pcs) by Type (2012-2022)
Figure United States Peptide Vaccine Sales Volume Market Share by Type (Product Category) in 2016
Figure Synthetic Peptide Vaccine Product Picture
Figure Others Product Picture
Figure United States Peptide Vaccine Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Peptide Vaccine by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Medical Center Examples
Table Key Downstream Customer in Medical Center
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Peptide Vaccine Market Size (Million USD) by Region (2012-2022)
Figure The West Peptide Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Peptide Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Peptide Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Peptide Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Peptide Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Peptide Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Peptide Vaccine Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Peptide Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Peptide Vaccine Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Peptide Vaccine Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Peptide Vaccine Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Peptide Vaccine Sales Share by Players/Suppliers
Figure 2017 United States Peptide Vaccine Sales Share by Players/Suppliers
Figure United States Peptide Vaccine Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Peptide Vaccine Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Peptide Vaccine Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Peptide Vaccine Revenue Share by Players/Suppliers
Figure 2017 United States Peptide Vaccine Revenue Share by Players/Suppliers
Table United States Market Peptide Vaccine Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Peptide Vaccine Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Peptide Vaccine Market Share of Top 3 Players/Suppliers
Figure United States Peptide Vaccine Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Peptide Vaccine Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Peptide Vaccine Product Category
Table United States Peptide Vaccine Sales (K Pcs) by Region (2012-2017)
Table United States Peptide Vaccine Sales Share by Region (2012-2017)
Figure United States Peptide Vaccine Sales Share by Region (2012-2017)
Figure United States Peptide Vaccine Sales Market Share by Region in 2016
Table United States Peptide Vaccine Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Peptide Vaccine Revenue Share by Region (2012-2017)
Figure United States Peptide Vaccine Revenue Market Share by Region (2012-2017)
Figure United States Peptide Vaccine Revenue Market Share by Region in 2016
Table United States Peptide Vaccine Price (USD/Pcs) by Region (2012-2017)
Table United States Peptide Vaccine Sales (K Pcs) by Type (2012-2017)
Table United States Peptide Vaccine Sales Share by Type (2012-2017)
Figure United States Peptide Vaccine Sales Share by Type (2012-2017)
Figure United States Peptide Vaccine Sales Market Share by Type in 2016
Table United States Peptide Vaccine Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Peptide Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Peptide Vaccine by Type (2012-2017)
Figure Revenue Market Share of Peptide Vaccine by Type in 2016
Table United States Peptide Vaccine Price (USD/Pcs) by Types (2012-2017)
Figure United States Peptide Vaccine Sales Growth Rate by Type (2012-2017)
Table United States Peptide Vaccine Sales (K Pcs) by Application (2012-2017)
Table United States Peptide Vaccine Sales Market Share by Application (2012-2017)
Figure United States Peptide Vaccine Sales Market Share by Application (2012-2017)
Figure United States Peptide Vaccine Sales Market Share by Application in 2016
Table United States Peptide Vaccine Sales Growth Rate by Application (2012-2017)
Figure United States Peptide Vaccine Sales Growth Rate by Application (2012-2017)
Table Inovio Pharmaceuticals Basic Information List
Table Inovio Pharmaceuticals Peptide Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Inovio Pharmaceuticals Peptide Vaccine Sales Growth Rate (2012-2017)
Figure Inovio Pharmaceuticals Peptide Vaccine Sales Market Share in United States (2012-2017)
Figure Inovio Pharmaceuticals Peptide Vaccine Revenue Market Share in United States (2012-2017)
Table Synthetic Genomics Basic Information List
Table Synthetic Genomics Peptide Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Synthetic Genomics Peptide Vaccine Sales Growth Rate (2012-2017)
Figure Synthetic Genomics Peptide Vaccine Sales Market Share in United States (2012-2017)
Figure Synthetic Genomics Peptide Vaccine Revenue Market Share in United States (2012-2017)
Table GreenPeptide Basic Information List
Table GreenPeptide Peptide Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GreenPeptide Peptide Vaccine Sales Growth Rate (2012-2017)
Figure GreenPeptide Peptide Vaccine Sales Market Share in United States (2012-2017)
Figure GreenPeptide Peptide Vaccine Revenue Market Share in United States (2012-2017)
Table AmbioPharm Basic Information List
Table AmbioPharm Peptide Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AmbioPharm Peptide Vaccine Sales Growth Rate (2012-2017)
Figure AmbioPharm Peptide Vaccine Sales Market Share in United States (2012-2017)
Figure AmbioPharm Peptide Vaccine Revenue Market Share in United States (2012-2017)
Table Rhapsody Biologics Basic Information List
Table Rhapsody Biologics Peptide Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Rhapsody Biologics Peptide Vaccine Sales Growth Rate (2012-2017)
Figure Rhapsody Biologics Peptide Vaccine Sales Market Share in United States (2012-2017)
Figure Rhapsody Biologics Peptide Vaccine Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Peptide Vaccine
Figure Manufacturing Process Analysis of Peptide Vaccine
Figure Peptide Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Peptide Vaccine Major Players/Suppliers in 2016
Table Major Buyers of Peptide Vaccine
Table Distributors/Traders List
Figure United States Peptide Vaccine Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Peptide Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Peptide Vaccine Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Peptide Vaccine Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Peptide Vaccine Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Peptide Vaccine Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Peptide Vaccine Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Peptide Vaccine Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Peptide Vaccine Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Peptide Vaccine Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Peptide Vaccine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Peptide Vaccine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Peptide Vaccine Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources